See also this year's filing and all EDGAR filings for this company.
PDF Report 0001818794_2023_Dyne_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001818794, Dyne Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 265,594,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,945,000 |
| 3 | remainder_Assets | 34,786,000 |
| 4 | LiabilitiesCurrent | 28,088,000 |
| 5 | LiabilitiesNoncurrent | 25,873,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 28,202,000 |
| 9 | ResearchAndDevelopmentExpense | 142,760,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 2,863,000 |
| 13 | remainder_ComprehensiveNetIncome | -302,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 306,325,000 |
| 1 | Liabilities | 53,961,000 |
| 2 | Expenses | 170,962,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 252,364,000 |
| 5 | NetIncome | -168,099,000 |
| 6 | ComprehensiveNetIncome | -168,250,000 |
| 7 | BaseVar | 267,206,500 |
| 8 | EconomicCapitalRatio | 1.48 |
Edgar->Model Mapping
Feature Distribution
Change over Time
